• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDC

MEDLAB CLINICAL LIMITED

0.00% ! $6.60
Currently unlisted.
Healthcare Biotechnology
Add to My Watchlist

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company specializes in the application of NanoCelle drug delivery technology to existing and new pharmaceuticals with the objective of empowering patients with chronic diseases and mental health conditions and enhancing their lives. Its drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress. It also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory. It is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MDC
Ann: Removal from Official List 		28/02/25 0 553
28/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  553 
MDC
Ann: Results of Meeting 2024 		14/02/25 0 373
14/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  373 
MDC
Ann: Results of Meeting 2023 		14/02/25 0 292
14/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  292 
MDC
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		11/02/25 3 1.6K
11/02/25 Last post  Traze Comments Created with Sketch.  3  Views Created with Sketch.  1.6K 
MDC
Ann: Notice of Annual General Meeting/Proxy Form 		29/01/25 4 1.9K
29/01/25 Last post  Traze Comments Created with Sketch.  4  Views Created with Sketch.  1.9K 
MDC
Ann: Long Term Suspended Entities 		16:40 0 342
16:40 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  342 
MDC
Ann: Notice of General Meeting/Proxy Form 		10/01/25 0 285
10/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  285 
MDC
Ann: MDC Board Composition Changes 		15/12/24 3 2.0K
15/12/24 Last post  jcurve Comments Created with Sketch.  3  Views Created with Sketch.  2.0K 

See All Discussions arrow Created with Sketch.

Timeline

Removal from Official List
28 Feb 09:20
 
Results of Meeting 2024
14 Feb 09:16
 
Results of Meeting 2023
14 Feb 09:15
 
Quarterly Activities/Appendix 4C Cash Flow Report
03 Feb 14:08
 
Long Term Suspended Entities
22 Jan 16:20
 
Notice of Annual General Meeting/Proxy Form
10 Jan 16:08
 
View More arrow Created with Sketch.

Featured News

NEWS Why most investors fail and how the top 20% succeed
right-arrow Created with Sketch.
BM8 Breakthrough 1,500 g/t Germanium Grades Identified at Bleiberg
right-arrow Created with Sketch.
NEWS From the Outback to the Andes: Why ASX-listed miners are moving into Latin America
right-arrow Created with Sketch.
NEWS Lakeview Now Better Than 500m in Strike and Open, Extended 125m East
right-arrow Created with Sketch.
NEWS Cygnus Intersects New High-Grade Gold with Visible Gold Identified in Subsequent Holes
right-arrow Created with Sketch.
NEWS From the Outback to the Andes: The experts speak - HotCopper webinar
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

GBC backs Almonty's tungsten push as gamechanger

GBC Investment Research is one of the lea­ding bank-in­de­pen­dent in­vest­ment hou­ses in Ger­ma­ny and an ex­pe­ri­en­ced is­suing ex­pert for Ger­man SMEs.As an ow­ner-ma­na­ged com­pa­ny, GBC AG knows the fi&s...
Almonty Industries: GBC starts coverage with 'BUY' and target price of C$4.20 In a world where securing critical raw materials is increasingly becoming a geopolitical priority, one company in particular is coming into focus: Almonty Industries Inc. (ASX:AII).
Where to find opportunities amid the trade war turmoil We explore whether it might be time to buy the likes of CBA (ASX:CBA), BHP Group (ASX:BHP), Santos (ASX:STO), and Woodside (ASX:WDS).
From the Outback to the Andes: The experts speak - HotCopper webinar HotCopper's guests and experts discuss why ASX-listed exploration and mining companies are investing in projects in Latin America, where some key jurisdictions are rolling out the welcome mat to foreign investment.
From the Outback to the Andes: Why ASX-listed miners are moving into Latin America Companies are finding projects in Latin America of a quality they say just isn't available in Australia anymore.

Featured News

NEWS Lakeview Now Better Than 500m in Strike and Open, Extended 125m East
right-arrow Created with Sketch.
NEWS From the Outback to the Andes: The experts speak - HotCopper webinar
right-arrow Created with Sketch.
NEWS From the Outback to the Andes: Why ASX-listed miners are moving into Latin America
right-arrow Created with Sketch.
BM8 Breakthrough 1,500 g/t Germanium Grades Identified at Bleiberg
right-arrow Created with Sketch.
NEWS Cygnus Intersects New High-Grade Gold with Visible Gold Identified in Subsequent Holes
right-arrow Created with Sketch.
NEWS Why most investors fail and how the top 20% succeed
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.